Investing.com -- CVS Health shares jumped about 5% in premarket trading Wednesday after the company raised its full-year profit guidance following better-than-expected second-quarter results. The healthcare group reported second-quarter earnings per share of $2.58, beating the analyst estimate of $1.83. Revenue rose 7.3% year-over-year to $106.1 billion, well ahead of the $100.03 billion consensus estimate. The group raised its full-year 2026 earnings guidance, now expecting adjusted EPS of $7.90 to $8.10, up from a prior range of $7.30 to $7.50 and above the $7.45 consensus estimate. Related articlesCVS shares jump on earnings beat, raised full-year guidanceJPMorgan outlines ten strategic themes that could shape the outlook for 2026Morgan Stanley CIO survey: Why AI hype isn't boosting 2026 IT budgets